In addition, Verma et al.45 found that elevated NK cells in peripheral blood may be associated with favorable therapeutic effects of chemotherapy on breast cancer patients, possibly through mechanisms such as promoting NKG2D expression and the presence of Granzyme B( +)/perforin( +) cells. This evidence concerns the gene KLRK1 and breast cancer.